Youll benefit from regular check-ins to monitor your progress, make necessary adjustments, and address any concerns
In healthy subjects, postprandial levels of GLP-1 rise, whereas patients with T2D or impaired glucose tolerance (IGT) exhibit reduced levels of meal-stimulated circulating GLP-1
You will not be able to receive a GLP-1 through the Bridge if any of the following apply: You currently receive a GLP-1 medication through your Medicare Part D plan
(30, 31) However, they also highlight potential cardiovascular and renal risks, emphasizing the need for careful perioperative monitoring and patient selection
Theyre expensive, especially when prescribed outside of diabetes treatment
Check the official website for current rates, as pricing may change